Oxford Biomedica. 2005 to see 'Huge value creation' (Panmure Gordon)

gULL - I expect the presentation of Trovax next month will be the start of the ball rolling for a Phase II farmout of this treatment. It doesn't ever have to reach the stage of FDA phase III acceptance ( I hope it does).

For our share priceto rise appreciably later in 2005, we need the farm out of Trovax, its the key. Everything suggests we will be in that position. For medium termers and traders, its this that makes the difference , the return to the upper 20's or even 30p region later in 2005. Everything else is a bonus to me.
We shall however, get good news from other treeatments I'm sure. Lets hope MetXa is not a dud!
H.